side effects of glp 1 long term Long-term Success GLP-1s Hinges on More Than Just a Prescription GLP-1 diabetes and weight-loss drug

The injectable form has high bioavailability, while oral semaglutide (Rybelsus) uses the SNAC absorption enhancer and has only ~1% oral bioavailability, requiring strict fasting conditions

Circulation (2019) 139:35161

How AOD 9604 Works AOD-9604 works mainly by interacting with fat metabolism processes in the body

Navo offers personalized Glutathione IV infusions tailored to your health and beauty goals

Real-World Examples: 250-Pound Person: Average loss: 56 pounds (22.5%) Final weight: 194 pounds Timeline: 18-20 months 200-Pound Person: Average loss: 45 pounds (22.5%) Final weight: 155 pounds Timeline: 18-20 months 300-Pound Person: Average loss: 67 pounds (22.5%) Final weight: 233 pounds Timeline: 20-24 months Dosing Schedule: Standard Escalation: Weeks 1-4: 2.5 mg weekly (starting dose) Weeks 5-8: 5 mg weekly Weeks 9-12: 7.5 mg weekly Weeks 13-16: 10 mg weekly (if tolerating well) Weeks 17-20: 12.5 mg weekly (if needed) Week 21+: 15 mg weekly (maximum dose for weight loss) Flexible Dosing: Not everyone needs maximum 15 mg dose Many achieve excellent results at 10 mg Provider adjusts based on results and tolerance Can stay at effective dose rather than pushing to maximum Side Effects: Most Common: Nausea: 30-37% (lower than semaglutide despite higher potency) Diarrhea: 19-23% Vomiting: 9-17% Constipation: 10-17% Abdominal discomfort: 8-11% Interesting Finding: Despite being more potent, tirzepatide causes less nausea and vomiting than semaglutide

SORT: KEY RECOMMENDATIONS FOR PRACTICE Table 1